|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-6-18
|
|
pubmed:abstractText |
A dose-escalation study of docetaxel combined with cisplatin, 5-fluorouracil, and concurrent radiotherapy (DCF-R) was performed to determine the optimal dose in patients with advanced esophageal carcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0167-8140
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
87
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
398-404
|
|
pubmed:meshHeading |
pubmed-meshheading:18405987-Adenocarcinoma,
pubmed-meshheading:18405987-Aged,
pubmed-meshheading:18405987-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18405987-Carcinoma, Squamous Cell,
pubmed-meshheading:18405987-Cisplatin,
pubmed-meshheading:18405987-Combined Modality Therapy,
pubmed-meshheading:18405987-Esophageal Neoplasms,
pubmed-meshheading:18405987-Female,
pubmed-meshheading:18405987-Fluorouracil,
pubmed-meshheading:18405987-Humans,
pubmed-meshheading:18405987-Lymphatic Metastasis,
pubmed-meshheading:18405987-Male,
pubmed-meshheading:18405987-Middle Aged,
pubmed-meshheading:18405987-Taxoids
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
A phase I trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma: Kitasato digestive disease & oncology group trial (KDOG 0501).
|
|
pubmed:affiliation |
Department of Gastroenterology, and Kitasato University School of Medicine, Kanagawa, Japan. k.higu@kitasato-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase I
|
